Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 22 | 2022 | 1663 | 2.140 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2021 | 1143 | 1.970 |
Why?
|
| Cognitive Dysfunction | 13 | 2022 | 1065 | 1.580 |
Why?
|
| Gait | 6 | 2021 | 413 | 1.300 |
Why?
|
| Hippocampus | 6 | 2020 | 278 | 1.230 |
Why?
|
| Exercise | 6 | 2021 | 473 | 1.040 |
Why?
|
| Cognition | 10 | 2022 | 1353 | 1.030 |
Why?
|
| Aged, 80 and over | 30 | 2022 | 4857 | 0.940 |
Why?
|
| Alzheimer Disease | 15 | 2022 | 2118 | 0.930 |
Why?
|
| Aging | 8 | 2021 | 1550 | 0.890 |
Why?
|
| Postural Balance | 3 | 2021 | 122 | 0.870 |
Why?
|
| Postmortem Changes | 2 | 2016 | 31 | 0.840 |
Why?
|
| Neuropathology | 3 | 2021 | 82 | 0.830 |
Why?
|
| Independent Living | 5 | 2021 | 318 | 0.820 |
Why?
|
| Wearable Electronic Devices | 5 | 2021 | 44 | 0.700 |
Why?
|
| White Matter | 5 | 2018 | 134 | 0.690 |
Why?
|
| Male | 37 | 2022 | 15292 | 0.670 |
Why?
|
| Female | 37 | 2022 | 15728 | 0.660 |
Why?
|
| Humans | 49 | 2022 | 28435 | 0.600 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 63 | 0.600 |
Why?
|
| Autopsy | 9 | 2021 | 343 | 0.590 |
Why?
|
| Aged | 27 | 2022 | 9278 | 0.580 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2018 | 53 | 0.570 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2018 | 113 | 0.540 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 704 | 0.500 |
Why?
|
| Motor Activity | 1 | 2018 | 329 | 0.490 |
Why?
|
| Thalamus | 3 | 2021 | 16 | 0.460 |
Why?
|
| Atrophy | 3 | 2021 | 93 | 0.460 |
Why?
|
| Knee Joint | 1 | 2019 | 746 | 0.420 |
Why?
|
| Parkinsonian Disorders | 3 | 2020 | 226 | 0.400 |
Why?
|
| Accelerometry | 4 | 2021 | 88 | 0.380 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 67 | 0.380 |
Why?
|
| Walking | 4 | 2022 | 260 | 0.370 |
Why?
|
| Neuroimaging | 3 | 2021 | 128 | 0.360 |
Why?
|
| Walking Speed | 2 | 2021 | 40 | 0.340 |
Why?
|
| Gray Matter | 3 | 2021 | 51 | 0.330 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 211 | 0.330 |
Why?
|
| Longitudinal Studies | 7 | 2021 | 1384 | 0.330 |
Why?
|
| Formaldehyde | 1 | 2009 | 9 | 0.320 |
Why?
|
| RNA, Messenger | 2 | 2022 | 308 | 0.310 |
Why?
|
| Temporal Lobe | 2 | 2020 | 84 | 0.300 |
Why?
|
| Cohort Studies | 9 | 2020 | 1926 | 0.290 |
Why?
|
| Brain Mapping | 3 | 2017 | 150 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 199 | 0.280 |
Why?
|
| Parkinson Disease | 4 | 2021 | 859 | 0.260 |
Why?
|
| Dementia | 2 | 2022 | 575 | 0.250 |
Why?
|
| Organ Size | 3 | 2015 | 100 | 0.240 |
Why?
|
| Nerve Net | 2 | 2021 | 41 | 0.220 |
Why?
|
| Sclerosis | 3 | 2019 | 66 | 0.210 |
Why?
|
| Transcriptome | 2 | 2022 | 86 | 0.200 |
Why?
|
| Neuropsychological Tests | 3 | 2022 | 1226 | 0.200 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 94 | 0.200 |
Why?
|
| DNA Methylation | 3 | 2019 | 165 | 0.200 |
Why?
|
| Tremor | 2 | 2021 | 117 | 0.190 |
Why?
|
| Proteome | 1 | 2022 | 42 | 0.190 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 9 | 0.190 |
Why?
|
| Proteomics | 1 | 2022 | 93 | 0.180 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2021 | 11 | 0.180 |
Why?
|
| Motor Skills | 1 | 2021 | 52 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 134 | 0.180 |
Why?
|
| Neuropeptides | 2 | 2019 | 27 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2019 | 110 | 0.180 |
Why?
|
| Frailty | 1 | 2021 | 35 | 0.180 |
Why?
|
| Hand Strength | 1 | 2021 | 60 | 0.180 |
Why?
|
| Sarcopenia | 1 | 2021 | 31 | 0.170 |
Why?
|
| Gene Expression | 2 | 2019 | 202 | 0.170 |
Why?
|
| Cognitive Aging | 1 | 2021 | 78 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 124 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2020 | 63 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 7 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 161 | 0.160 |
Why?
|
| Cognition Disorders | 3 | 2017 | 1003 | 0.160 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 18 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 109 | 0.160 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 13 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 26 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 85 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2021 | 139 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2021 | 125 | 0.160 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2018 | 10 | 0.160 |
Why?
|
| Memory | 3 | 2017 | 302 | 0.160 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 42 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2019 | 85 | 0.150 |
Why?
|
| Muscle Strength | 1 | 2019 | 136 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 12 | 0.150 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 24 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2017 | 5 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 289 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 75 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 39 | 0.140 |
Why?
|
| Ultraviolet Therapy | 1 | 2017 | 1 | 0.140 |
Why?
|
| Young Adult | 6 | 2021 | 2070 | 0.140 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 24 | 0.140 |
Why?
|
| Linear Models | 2 | 2016 | 251 | 0.140 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.140 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.140 |
Why?
|
| Plasmacytoma | 1 | 2016 | 8 | 0.140 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 14 | 0.130 |
Why?
|
| Femur | 1 | 2020 | 382 | 0.130 |
Why?
|
| Skin Diseases | 1 | 2017 | 26 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 87 | 0.130 |
Why?
|
| Adult | 10 | 2021 | 8107 | 0.130 |
Why?
|
| Neurons | 1 | 2019 | 342 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 155 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 171 | 0.130 |
Why?
|
| Neocortex | 1 | 2016 | 31 | 0.130 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 63 | 0.130 |
Why?
|
| Algorithms | 2 | 2019 | 378 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 352 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 74 | 0.120 |
Why?
|
| Middle Aged | 8 | 2021 | 9270 | 0.110 |
Why?
|
| Joint Instability | 1 | 2019 | 394 | 0.110 |
Why?
|
| Locomotion | 1 | 2014 | 24 | 0.110 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 369 | 0.100 |
Why?
|
| Shoulder Joint | 1 | 2019 | 645 | 0.100 |
Why?
|
| Models, Anatomic | 1 | 2010 | 39 | 0.090 |
Why?
|
| Memory, Episodic | 1 | 2011 | 116 | 0.090 |
Why?
|
| Mortality | 2 | 2021 | 90 | 0.080 |
Why?
|
| Fixatives | 1 | 2009 | 6 | 0.080 |
Why?
|
| Sex Factors | 2 | 2021 | 475 | 0.080 |
Why?
|
| Risk Factors | 3 | 2021 | 2408 | 0.080 |
Why?
|
| Chicago | 2 | 2021 | 947 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 194 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 274 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 169 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 730 | 0.060 |
Why?
|
| Photosensitivity Disorders | 1 | 2003 | 1 | 0.050 |
Why?
|
| Sunlight | 1 | 2003 | 1 | 0.050 |
Why?
|
| Urticaria | 1 | 2003 | 4 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 737 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 2309 | 0.050 |
Why?
|
| Depression | 2 | 2017 | 452 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 19 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 38 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 75 | 0.050 |
Why?
|
| Executive Function | 1 | 2022 | 115 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2021 | 30 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 825 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2021 | 53 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 221 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 117 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Nestin | 1 | 2019 | 3 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2019 | 14 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 8 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2019 | 8 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2020 | 94 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 19 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1859 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 13 | 0.040 |
Why?
|
| Software | 1 | 2019 | 65 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3612 | 0.040 |
Why?
|
| Life Style | 1 | 2020 | 201 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 51 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 125 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 43 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2019 | 539 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 47 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 781 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2018 | 266 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 933 | 0.040 |
Why?
|
| Netrin Receptors | 1 | 2017 | 5 | 0.040 |
Why?
|
| Shoulder Injuries | 1 | 2019 | 147 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 44 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 718 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 773 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 37 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2017 | 10 | 0.030 |
Why?
|
| Child | 2 | 2017 | 1421 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 988 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 62 | 0.030 |
Why?
|
| Phototherapy | 1 | 2017 | 36 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 221 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 86 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 40 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 145 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 608 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 284 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 283 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 359 | 0.030 |
Why?
|
| Actigraphy | 1 | 2016 | 99 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1809 | 0.030 |
Why?
|
| United States | 1 | 2021 | 2200 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 137 | 0.030 |
Why?
|
| Muscle Rigidity | 1 | 2014 | 21 | 0.030 |
Why?
|
| Hypokinesia | 1 | 2014 | 23 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 49 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 176 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 355 | 0.020 |
Why?
|
| Stroke | 1 | 2016 | 276 | 0.020 |
Why?
|
| Cadaver | 1 | 2013 | 376 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 518 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 640 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2003 | 689 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1491 | 0.010 |
Why?
|